Matthew R. Porter

Structure-Based Optimization of ML300-Derived, Noncovalent Inhibitors Targeting the Severe Acute Respiratory Syndrome Coronavirus 3CL Protease (SARS-CoV-2 3CL^pro)

Sang Hoon Han, Christopher M. Goins, T. Arya et al. · Journal of Medicinal Chemistry · 2021 · 135 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14

Stereoselective Dynamic Cyclization of Allylic Azides: Synthesis of Tetralins, Chromanes, and Tetrahydroquinolines

Matthew R. Porter, Rami M. Shaker, Cristian Calcanas et al. · Journal of the American Chemical Society · 2018 · 52 citations

Natural Sciences, Chemistry, Catalysis +9

Intestinal Epithelial Barrier Disruption through Altered Mucosal MicroRNA Expression in Human Immunodeficiency Virus and Simian Immunodeficiency Virus Infections

Christopher A. Gaulke, Matthew R. Porter, Yanhong Han et al. · Journal of Virology · 2014 · 31 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

3-Amino-chromanes and Tetrahydroquinolines as Selective 5-HT_2B, 5-HT₇, or σ₁ Receptor Ligands

Matthew R. Porter, Haiyan Xiao, Jing Wang et al. · ACS Medicinal Chemistry Letters · 2019 · 18 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

The collaborative effect of scientific meetings: A study of the International Milk Genomics Consortium

Eric S. C. Kwok, Matthew R. Porter, Ian Korf et al. · PLoS ONE · 2018 · 12 citations · Full text

Life Sciences, Dairy Science, Community Engagement +12